End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.4 TWD | +0.79% | -6.10% | +27.00% |
04-15 | Orient Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Orient Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Business Summary
Number of employees: 173
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Factory Operations
95.2
%
| 446 | 87.2 % | 847 | 95.2 % | +89.82% |
Global Business
4.4
%
| 63 | 12.3 % | 39 | 4.4 % | -38.14% |
Medical Affairs
0.4
%
| 3 | 0.5 % | 4 | 0.4 % | +50.24% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
76.4
%
| 254 | 49.6 % | 680 | 76.4 % | +167.88% |
United States
20.1
%
| 216 | 42.2 % | 178 | 20.1 % | -17.46% |
Philippines
2.7
%
| - | - | 24 | 2.7 % | - |
Others
0.9
%
| 4 | 0.8 % | 8 | 0.9 % | +99.23% |
China
0.0
%
| 38 | 7.4 % | 0 | 0.0 % | -99.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chi Tai Chang
CEO | Chief Executive Officer | - | - |
Chia Ying Chen
DFI | Director of Finance/CFO | - | - |
Meng Lin Tsai
BRD | Director/Board Member | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Hung Tsai
CHM | Chairman | - | 14/01/08 |
Wei Chao Kao
BRD | Director/Board Member | - | - |
Kang Chi Chou
BRD | Director/Board Member | - | 09/06/19 |
Han Liang Hu
BRD | Director/Board Member | 57 | - |
Tai Ming Chen
BRD | Director/Board Member | - | 22/06/16 |
Yu Ling Li
BRD | Director/Board Member | - | - |
Wen Hung Huang
BRD | Director/Board Member | - | - |
Wen Chieh Sung
BRD | Director/Board Member | - | - |
Chia Yue Chang
BRD | Director/Board Member | - | - |
Sheng Che Lin
BRD | Director/Board Member | - | 09/06/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 223,035,000 | 34,031,431 ( 15.26 %) | 0 | 15.26 % |
Company contact information
Orient Pharma Co., Ltd.
2nd Floor 368, Section 1, Fuhsing South Road
106 56, Taipei
+
http://www.oppharma.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+27.00% | 173M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- 4166 Stock
- Company Orient Pharma Co., Ltd.